Related Experiment Videos
Kava as an anticraving agent: preliminary data
1ggsteiner@yahoo.com
Pacific Health Dialog
|August 16, 2002
Summary
Kava may reduce drug cravings. Preliminary studies suggest its active compounds, kavapyrones, may decrease desire for substances like alcohol and tobacco, potentially aiding addiction treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Drug and alcohol abuse poses significant financial and social costs in the U.S.
- Understanding the neurological basis of craving is crucial for effective addiction treatment.
- Kava's active compounds, kavapyrones, interact with brain sites linked to addiction and craving.
Purpose of the Study:
- To investigate kava's potential to reduce craving for substances of abuse.
- To explore the effects of kavapyrones on addiction and withdrawal symptoms.
Main Methods:
- A craving survey and pilot study were conducted.
- Examined cravings for alcohol, tobacco, cocaine, and heroin.
- One investigation used a standardized amount of kavapyrones versus a placebo.
Main Results:
- Participants reported a reduced desire for their drug of choice.
- A standardized dose of kavapyrones showed a difference in alcohol abstinence rates between groups.
- Preliminary findings suggest kava may reduce addiction-related craving.
Conclusions:
- Kava shows potential as an adjunct therapy for addiction treatment.
- Further large-scale, systematic investigations are warranted.
- Kava may be particularly beneficial for Native Hawaiian and Pacific populations.